Plasma Membrane Channel TRPM4 Mediates Immunogenic Therapy–Induced Necrosis

Abstract

A genome-wide CRISPR screen reveals a pivotal role for TRPM4 in cell death and immune activation following treatment with diverse necrosis-inducing anticancer therapies, which could facilitate development of necrosis-based cancer immunotherapies.